Harbor MedTech
Medical Equipment ManufacturingCalifornia, United States11-50 Employees
Harbor MedTech, Inc., based in Irvine, CA, is a diversified and fully integrated tissue regeneration company founded in 2010. Our proprietary technology enables us to deliver the first cost-effective best-in-class biologic solutions globally for treatment of damaged soft tissue. We are focused on two important health issues. First is the treatment of serious skin wounds caused by diabetes, vascular disease, and trauma. The second is bio-compatible and durable reinforcement of surgical repair of hernias, torn tendons and ligaments, and breast reconstruction following cancer surgery. Our first product, Architect®, is a unique biologic extracellular collagen matrix produced with our patented BriDGE® collagen stabilization technology. Architect® is FDA cleared and CE Mark certified for use as “skin substitute” for treating diabetic ulcers, venous ulcers, pressure sores, and many other serious skin wounds. Published clinical studies indicate that Architect® may be more effective in healing skin wounds than today’s leading human tissue derived products, but Architect® is much more convenient to store and use, and treating these serious skin wounds can be accomplished at a much lower cost.